CFO of Egetis Therapeutics acquires shares
Refinitiv閱讀少於1分鐘
Stockholm, Sweden, July 17, 2025. Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (NASDAQ Stockholm: EGTX), today announced that Yilmaz Mahshid, Chief Financial Officer, has acquired 35,000 shares in Egetis. This investment in Egetis is an ad hoc investment and is not part of any Long Term Incentive plan.
登入或建立一個永久免費帳戶來閱讀此新聞